tiprankstipranks
Trending News
More News >

Mercer Investments Ceases Substantial Holding in Microba Life Sciences

Story Highlights
Mercer Investments Ceases Substantial Holding in Microba Life Sciences

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Microba Life Sciences Limited ( (AU:MAP) ).

Mercer Investments (Australia) Limited, as the responsible entity of the Mercer Australian Small Companies Fund, has ceased to be a substantial holder in Microba Life Sciences Limited as of June 27, 2025. This change follows an increase in the total shares on issue by 67,177,796 shares, impacting the fund’s voting interests in the company.

The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.26 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.

More about Microba Life Sciences Limited

Microba Life Sciences Limited operates in the life sciences industry, focusing on microbiome analysis and related health solutions. The company is engaged in providing insights into gut health through advanced technology and scientific research, catering to both individual consumers and healthcare professionals.

Average Trading Volume: 256,045

Technical Sentiment Signal: Sell

Current Market Cap: A$44.81M

For detailed information about MAP stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1